Cryptophanes with high xenon affinity enable ultrasensitive detection of analytes in solution using Xe-129 NMR/MRI
Technology Overview:
The Dmochowski Lab has developed biosensors comprised of tri-functionalized cryptophane with high affinity for hyperpolarized 129Xe. These biosensors can be designed to detect molecular markers associated with cancer and other disease. More specifically, a biosensor has been synthesized that detects matrix metalloproteases (MMPs), which are frequently upregulated in many cancers.
The MMP enzyme cleaves the peptide covalently attached to the 129Xe biosensor, resulting in a change in the chemical environment of 129Xe readily detectable by a 0.5 ppm chemical shift in NMR. The features of these tri-functionalized cryptophanes enable the detection of picomolar concentrations of cryptophane biosensors by a technique known as Hyper-CEST NMR/MRI. Additional xenon biosensors have been designed to target integrin receptors, folate receptor, and carbonic anhydrase. In most cases, binding the cryptophane biosensor to its protein target produces a measureable change in the Xe-129 NMR chemical shift.
Advantages:
- Tri-functionalized cryptophanes well-solubilized in water
- Highest known affinity for xenon
- Very favorable Xe exchange kinetics
- Ultrasensitive analyte detection
- Tri-functionalized cryptophane biosensors can be designed that each yield distinct 129Xe NMR chemical shifts and can be targeted to different biomarkers
Applications:
- Biosensors
- 129Xe MRI diagnostics next-generation platform
- Biomolecular imaging and enhancement of existing 1H MRI technology
From Khan et al, 2015. Folate-conjugated cryptophane to target cryptophane to membrane-bound folate receptors that are overexpressed in many human cancers.
Stage of Development:
In vitro proof-of-concept testing
Reference Media:
- Riggle B.A. et al. J Am Chem Soc, 2015 Apr 29, 137(16): 5542.
- Taratula O. et al. Supramol. Chem., 2015 Jan 1, 27(1-2): 65.
- Khan N.S. et al. Bioconjugate Chem., 2015, 26(1): 101.
- Taratula O. et al. Org Lett, 2012 July 20, 14(14): 3580.
- Taratula O. et al. Org Lett, 2011 Mar 18, 13(6): 1414.
- Bai Y. et al. Anal Chem, 2012 Nov 20, 84(22): 9935.
- Hill PA et al. J Am Chem Soc, 2007 Aug 1, 129(30): 9262.
Case ID:
T4532-tpNCS
Web Published:
3/9/2020
Patent Information:
| App Type |
Country |
Serial No. |
Patent No. |
File Date |
Issued Date |
Expire Date |